Tyroserleutide

· Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Tyroserleutide, covering 2008-03-26 to 2018-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Expanding Phase III Study of Tyroserleutide for Injection [Phase 3]